S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
pixel
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
pixel
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
pixel
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
pixel

Ulta Beauty (NASDAQ:ULTA) Updates FY 2021 Earnings Guidance

Last updated on Wednesday, September 22, 2021 | 2021 MarketBeat

Ulta Beauty (NASDAQ:ULTA) updated its FY 2021 earnings guidance on Wednesday. The company provided EPS guidance of $14.500-$14.700 for the period, compared to the Thomson Reuters consensus EPS estimate of $12.280. The company issued revenue guidance of $8.10 billion-$8.30 billion, compared to the consensus revenue estimate of $7.88 billion.

Several equities analysts recently weighed in on the stock. Piper Sandler increased their price target on shares of Ulta Beauty from $386.00 to $405.00 and gave the stock an overweight rating in a report on Monday, August 23rd. Loop Capital reiterated a hold rating and issued a $400.00 price target on shares of Ulta Beauty in a report on Friday, September 17th. Oppenheimer increased their price target on shares of Ulta Beauty from $415.00 to $450.00 and gave the stock an outperform rating in a report on Thursday, August 26th. Robert W. Baird increased their price target on shares of Ulta Beauty from $390.00 to $460.00 and gave the stock an outperform rating in a report on Thursday, August 26th. Finally, UBS Group upped their price objective on Ulta Beauty from $415.00 to $455.00 and gave the stock a buy rating in a research report on Thursday, August 26th. Eight analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of Buy and a consensus price target of $401.00.

NASDAQ ULTA opened at $369.84 on Wednesday. The business has a fifty day moving average price of $362.14 and a 200 day moving average price of $340.05. Ulta Beauty has a one year low of $200.50 and a one year high of $414.98. The company has a market cap of $20.10 billion, a P/E ratio of 28.43, a P/E/G ratio of 1.51 and a beta of 1.71.

Ulta Beauty (NASDAQ:ULTA) last posted its quarterly earnings data on Tuesday, August 24th. The specialty retailer reported $4.56 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $2.56 by $2.00. Ulta Beauty had a return on equity of 40.49% and a net margin of 9.50%. The firm had revenue of $1.97 billion during the quarter, compared to the consensus estimate of $1.76 billion. During the same period in the prior year, the company earned $0.73 EPS. The firm's revenue was up 60.2% compared to the same quarter last year. On average, research analysts predict that Ulta Beauty will post 15.04 EPS for the current fiscal year.

In related news, Director Michael R. Macdonald sold 5,700 shares of the stock in a transaction on Thursday, August 5th. The stock was sold at an average price of $350.04, for a total value of $1,995,228.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 3.10% of the stock is currently owned by corporate insiders.

About Ulta Beauty

Ulta Beauty, Inc engages in the retail of beauty products. Its products include makeup, skin care, tools and brushes, fragrance, and bath and body. The company was founded on January 9, 1990 and is headquartered in Bolingbrook, IL.

Further Reading: How Does the Quiet Period Work?

Earnings History and Estimates for Ulta Beauty (NASDAQ:ULTA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $1,000 in Ulta Beauty right now?

Before you consider Ulta Beauty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ulta Beauty wasn't on the list.

While Ulta Beauty currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.